Amarin Corp Plc (AMRN)

[KCSVEN]

I think market was looking to see if they could hit 80 and well short. Interestingly the first slide says 80% script increase YOY and 67% Net Revenue Increase. If revenue and script increase were both 80% you get $79 for the quarter. More where street was looking for.


I think 2Q will see a significant jump in price per script and inventory purchases that will likely make up for some of that 6 million dollar shortfall.

If they grow 15% Q over Q the rest of year and makeup the 6 million you get about 87, 103, and 118 and then 381 total for the year. Just above $350 consensus. Which would mean, barring another sales force influx in 4Q they should be positive net income in Q4.

They keep saying 5 visits to increase scripts, should see better effect as time goes on with better trained sales force etc...but when will they really hit there stride?


If they get priority review then 4Q could change revenue estimates quickly. If standard review then they need to really start seeing prescription growth to get $400 million.